Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

PDL BioPharma Inc (NASDAQ:PDLI)

2.91
Delayed Data
As of Feb 09
 -0.05 / -1.69%
Today’s Change
2.58
Today|||52-Week Range
7.43
-17.80%
Year-to-Date

Today’s Trading

Previous close2.96
Today’s open2.89
Day’s range2.89 - 3.01
Volume2,398,336
Average volume (3 months)3,328,644
Market cap$484.2M
Dividend yield6.87%
Data as of 02/09/2016

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+4.12%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio1.7
Price/Sales2.30
Price/Book1.04

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...-0.05-0.37%
SRPTSarepta Therapeutics...+0.44+4.10%
EPZMEpizyme Inc+0.31+3.45%
RVNCRevance Therapeutics...-0.52-2.95%
Data as of 02/09/2016

Financials

Next reporting dateFebruary 29, 2016
EPS forecast (this quarter)$0.54
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

Partner Offers